Land: Bangladesh
Sprog: engelsk
Kilde: DGDA (Directorate General of Drug Administration)
Dexamethasone
Ibn Sina Pharmaceutical Ind. Ltd.
Dexamethasone
1 mg/ml
Eye Drops
Dexon Dexamethasone 1% & 0.05% Composition Dexon eye & ear drops: Each ml solution contains Dexamethasone Sodium Phosphate BP equivalent to Dexamethasone 1 mg. Dexon eye ointment: Each gm ointment contains Dexamethasone Sodium Phosphate USP equivalent to Dexamethasone 0.5 mg. Description Dexon (Dexamethasone) is a glucocorticoid drug. It suppresses the inflammatory response to a variety of agents. Indication Dexon is indicated in the treatment of the following conditions: Ophthalmic: Dexon is indicated in the non-infectious forms of conjunctivitis, keratitis & blepharitis, especially of allergic origin, inflammation of the anterior uvea (iritis, iridocyclitis), scleritis, episcleritis and orbital myositis. Dexon is also indicated for the treatment of corneal injury from chemical, radiation or thermal burns or following penetration by foreign bodies. Otic: Dexon is indicated in the steroid responsive inflammatory conditions of the external auditory meatus, such as: allergic otitis externa, selected purulent and non-purulent infective otitis externa. Dosage & administration Ophthalmic: Instill one or two drops of solution into the conjunctival sac every hour during the day and every two hour during the night as initial therapy. When a favorable response is observed, reduce dosage to one drop every four hours. Later, further reduction to one drop three or four times daily may be sufficient to control symptoms. Otic: Clean aural canal thoroughly and sponge to dry. Initially instill three or four drops two or three times a day. When a favorable response is obtained, reduce dosage gradually and eventually discontinue. However, the duration of treatment in both cases will vary with the type of lesions and may extend from a few days to several weeks according to therapeutic response. Eye ointment : Apply a thin film of ointment equally into the conjunctival sac(s) up to four times daily. When a favorable response is observed, dosage may be reduced gradually to twice daily and later once daily application for several days Læs hele dokumentet